Is Pacer BioThreat Strategy stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Pacer BioThreat Strategy pays dividends. Last time was Wednesday 2nd of October 2024 where the investors holding the stock on Thursday 26th of September 2024 were paid $0.072301 per share. Over the last 16 times between 2020 and 2024, Pacer BioThreat Strategy has paid $1.14750892 with an average of $0.07 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Pacer BioThreat Strategy 10 years ago, but if you had invested on Thursday 25th of June 2020 when the price was $24.74, you would have made a profit of $15.29 per share or 61.80%
No, the average daily trading liquidity for Pacer BioThreat Strategy is $445 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Pacer BioThreat Strategy has no real debt, which is good in periods of high inflation. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.
We have calculated the inflation risk for Pacer BioThreat Strategy to be medium [0.6 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.